Andrzej T. Slominski, MD, PhD, University of Alabama at Birmingham

Andrzej T. Slominski, MD, PhD
Andrzej T. Slominski, MD, PhD

Dr. Slominski's recent focus is on neuroendocrinology of the skin, cancer, photobiology, pigment biology, cutaneous steroidogenesis, vitamin D plus novel secosteroids and melatonin. His academic track record is marked by discoveries of cutaneous expression of classical hypothalamic and pituitary hormones, discoveries of cutaneous serotoninergic and melatoninergic systems, an defining the skin as a neuroendocrine organ. Most important is the discovery of new seco/steroidogenic pathways.



  1. Slominski A, Moellmann G, Kuklinska E. MSH inhibits growth in a line of amelanotic hamster melanoma cells and induces increases in cyclic AMP levels and tyrosinase activity without inducing melanogenesis. J Cell Sci. 1989 Apr;92 ( Pt 4):551-9. PubMed PMID: 2557357.
  2. Slominski A, Moellmann G, Kuklinska E, Bomirski A, Pawelek J (1988) Positive regulation of melanin pigmentation by two key substrates of the melanogenic pathway: L-tyrosine and L-dopa. J Cell Sci 89, 287-296.
  3. Slominski A (1991). POMC gene expression in hamster and mouse melanoma cells. FEBS Lett 291, 165-168